Literature DB >> 20554989

Acute myeloid leukemia and the Wnt pathway.

Connie J Eaves1, R Keith Humphries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20554989     DOI： 10.1056/NEJMcibr1003522

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

1.  Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia.

Authors:  Xuejie Jiang; Po Yee Mak; Hong Mu; Wenjing Tao; Duncan H Mak; Steven Kornblau; Qi Zhang; Peter Ruvolo; Jared K Burks; Weiguo Zhang; Teresa McQueen; Rongqing Pan; Hongsheng Zhou; Marina Konopleva; Jorge Cortes; Qifa Liu; Michael Andreeff; Bing Z Carter
Journal:  Clin Cancer Res       Date:  2018-02-20       Impact factor: 12.531

2.  microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.

Authors:  R Su; L Dong; D Zou; H Zhao; Y Ren; F Li; P Yi; L Li; Y Zhu; Y Ma; J Wang; F Wang; J Yu
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

3.  Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines.

Authors:  Jun Li
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

Review 4.  Self-renewal related signaling in myeloid leukemia stem cells.

Authors:  Florian H Heidel; Brenton G Mar; Scott A Armstrong
Journal:  Int J Hematol       Date:  2011-07-29       Impact factor: 2.490

5.  CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.

Authors:  Christian Schürch; Carsten Riether; Matthias S Matter; Alexandar Tzankov; Adrian F Ochsenbein
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

Review 6.  Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development.

Authors:  T C Luis; M Ichii; M H Brugman; P Kincade; F J T Staal
Journal:  Leukemia       Date:  2011-12-15       Impact factor: 11.528

7.  T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

Authors:  Armen Mardiros; Cedric Dos Santos; Tinisha McDonald; Christine E Brown; Xiuli Wang; L Elizabeth Budde; Lauren Hoffman; Brenda Aguilar; Wen-Chung Chang; William Bretzlaff; Brenda Chang; Mahesh Jonnalagadda; Renate Starr; Julie R Ostberg; Michael C Jensen; Ravi Bhatia; Stephen J Forman
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

8.  Laminarin Promotes Immune Responses and Normalizes Glutamic Oxaloacetic Transaminase and Glutamic Pyruvic Transaminase Levels in Leukemic Mice In Vivo.

Authors:  Hung-Sheng Shang; Yung-Luen Shih; Chao-Ping Chen; Mei-Hui Lee; Hsu-Feng Lu; Pei-Yi Chou; Nien-Chieh Liao; Yung-Liang Chen; Shu-Ching Hsueh; Jing-Gung Chung
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

9.  PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia.

Authors:  Duanfeng Jiang; Yanjuan He; Qiuyu Mo; Enyi Liu; Xin Li; Lihua Huang; Qin Zhang; Fangping Chen; Yan Li; Haigang Shao
Journal:  J Transl Med       Date:  2021-05-17       Impact factor: 5.531

10.  Demethoxycurcumin Promotes Macrophage Cell Population and Phagocytosis in WEHI-3 Cell-generated Leukemia BALB/c Mice In Vivo.

Authors:  Yi-Jia Lin; Chiung-Ju Chen; Shu-Ching Hsueh; Mei-Hui Lee; Shu-Fen Peng; Hsu-Feng Lu; Kung-Wen Lu; Wen-Wen Huang; Kuo-Ching Liu; Yung-Liang Chen; Yung-Luen Shih; Jin-Cherng Lien
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.